MedPath

18F-NaF-PET for Identification of TCFA

Conditions
Acute Coronary Syndrome
Registration Number
NCT02388412
Lead Sponsor
Seoul National University Hospital
Brief Summary

Recently, positron emission tomography(PET) using 18F-Sodium fluoride (NaF) showed promising results for detecting vulnerable plaques in some pilot studies.

In this study, the investigators will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque, diagnosed by optical coherence tomography (OCT).

Detailed Description

It has been well known that mechanism of acute coronary syndrome is plaque rupture and occlusion of coronary artery by this plaque rupture. Until now, evaluation of vulnerable plaque have been mainly performed with invasive imaging modalities such as optical coherence tomography or intravascular ultrasound.

Recently, positron emission tomography(PET) using 18F-Sodium fluoride (NaF) showed promising results for detecting vulnerable plaques in some pilot studies.

In this study, we will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque, diagnosed by optical coherence tomography (OCT).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
96
Inclusion Criteria
    1. Patients with angina pectoris who are scheduled to do invasive coronary angiography.
    1. Patients who have moderate (40-70%) stenosis at proximal or mid-portion of major coronary arteries. Confirmed by coronary CT angiography.
    1. Patients who are anticipated coronary artery disease.(Probability > 90 %)
    1. Acute coronary syndrome.
Read More
Exclusion Criteria
    1. Stenosis at distal coronary or small vessel.
    1. Patients who don't have moderate (40-70%) stenosis at proximal or mid-portion of major coronary arteries. Confirmed by invasive coronary angiography.
    1. Inadequate quality of 18F-NaF PET-CT
    1. Inadequate quality of Optical Coherence Tomography (OCT), IVUS, Coronary CT angiography
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference of tissue background ratio measured by 18F-NaF PET between Vulnerable and non-vulnerable plaqueup to 1 week

Difference of tissue background ratio measured by 18F-NaF PET between Vulnerable and non-vulnerable plaque

Secondary Outcome Measures
NameTimeMethod
Target vessel revascularization1 year

Between High-TBR and Low-TBR Plaque

Cardiac death and all-cause mortality1 year

Between High-TBR and Low-TBR Plaque

Differencce of Maximum SUV value between Vulnerable and non-vulnerable plaqueup to 1 week

Tissue-to-background ratios were calculated for each participant by dividing the maximal SUV measured in aortic valves by the mean SUV of blood in inferior vena cava

Number of participants demonstrating at least 1 low-attenuation coronary atherosclerotic plaqueup to 1 week

Number of participants demonstrating at least 1 low-attenuation coronary atherosclerotic plaque

Non-fatal target vessel myocardial infarction1 year

Between High-TBR and Low-TBR Plaque

Target vessel restenosis1 year

Between High-TBR and Low-TBR Plaque

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath